Breaking News Instant updates and real-time market news.

TBPH

Theravance Biopharma

$29.79

-0.07 (-0.23%)

16:31
08/08/17
08/08
16:31
08/08/17
16:31

Theravance Biopharma reports Q2 EPS ($1.27), consensus ($1.14)

Reports Q2 revenue $3.5M, consensus $4.66M.

  • 08

    Aug

  • 08

    Aug

TBPH Theravance Biopharma
$29.79

-0.07 (-0.23%)

06/16/17
CANT
06/16/17
INITIATION
Target $55
CANT
Overweight
Theravance Biopharma initiated with an Overweight at Cantor
Cantor Fitzgerald analyst Louise Chen started Theravance Biopharma with an Overweight rating and $55 price target.
05/10/17
LEER
05/10/17
NO CHANGE
Target $47
LEER
Outperform
Theravance Biopharma price target raised to $47 from $34 at Leerink
Leerink analyst Geoffrey Porges raised his price target Theravance Biopharma to $47 from $34 after the company reported Q1 financial results and provided an update for investors about its development progress and upcoming milestones. The analyst reiterates an Outperform rating on the shares.
03/29/17
PIPR
03/29/17
NO CHANGE
Target $42
PIPR
Overweight
Mylan news a positive for Theravance, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says Mylan's (MYL) complete response letter for its generic version of GlaxoSmithKline's Advair "buys time and will likely preserve some pricing power in the broader respiratory space." This will be important for GSK's commercialization of the closed triple following potential regulatory approval at year end, Schimmer tells investors in a research note. This is also positive for Theravance Biopharma (TBPH), which stands to receive a "meaningful" mid/high single digit royalty on the closed triple, the analyst contends. He reiterates an Overweight rating on Theravance with a $42 price target. The stock is up 49c to $36.47 in afternoon trading.
03/22/17
PIPR
03/22/17
NO CHANGE
Target $42
PIPR
Overweight
Theravance one program away from joining Incyte, says Piper Jaffray
After hosting meetings with management, Piper Jaffray analyst Joshua Schimmer reiterates Theravance Biopharma (TBPH) as a top mid-cap pick. The analyst has an Overweight rating on the shares with a $42 price target. Schimmer increasingly sees Theravance as one of the most likely mid-caps to make the jump to be the next Incyte (INCY). The company is just one major program away from joining the ranks of Incyte and BioMarin (BMRN), he tells investors in a research note.

TODAY'S FREE FLY STORIES

14:35
12/10/18
12/10
14:35
12/10/18
14:35
General news
Treasury Action: yields have mostly edged up as Wall Street recovers »

Treasury Action: yields…

GD

General Dynamics

$170.66

3.28 (1.96%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Hot Stocks
General Dynamics awarded $346.5M contract modification »

General Dynamics Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

F

Ford

$8.49

-0.33 (-3.74%)

14:31
12/10/18
12/10
14:31
12/10/18
14:31
Periodicals
Ford in talks with workers at German plant about job cuts, Reuters reports »

Ford confirmed that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 23

    Jan

  • 25

    Apr

  • 24

    Jul

  • 23

    Oct

VLRX

Valeritas

$0.36

0.0296 (9.03%)

14:27
12/10/18
12/10
14:27
12/10/18
14:27
Hot Stocks
Breaking Hot Stocks news story on Valeritas »

Empery Asset Management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NIO

NIO Inc.

$6.90

-0.1 (-1.43%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Options
NIO Inc call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PETQ

PetIQ

$29.38

-2.08 (-6.61%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Conference/Events
PetIQ management to meet with William Blair »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

KAI

Kadant

$80.36

-2.34 (-2.83%)

14:25
12/10/18
12/10
14:25
12/10/18
14:25
Conference/Events
Kadant to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 20

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
12/10/18
12/10
14:17
12/10/18
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
12/10/18
12/10
14:16
12/10/18
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YELP

Yelp

$35.67

1.07 (3.09%)

, P

Pandora

$8.63

-0.1 (-1.15%)

14:14
12/10/18
12/10
14:14
12/10/18
14:14
Recommendations
Yelp, Pandora, Web.com analyst commentary  »

Yelp could be worth…

YELP

Yelp

$35.67

1.07 (3.09%)

P

Pandora

$8.63

-0.1 (-1.15%)

WEB

Web.com

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

BBT

BB&T

$46.94

-0.72 (-1.51%)

14:10
12/10/18
12/10
14:10
12/10/18
14:10
Options
4.5K Dec 44 - 46 put spreads trade 45c as BB&T shares drop 1.6% to $46.88 »

4.5K Dec 44 - 46 put…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 18

    Oct

DLTR

Dollar Tree

$83.55

0.155 (0.19%)

14:07
12/10/18
12/10
14:07
12/10/18
14:07
Conference/Events
Dollar Tree management to meet with UBS »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

AGNC

AGNC Investment

$17.81

-0.01 (-0.06%)

14:05
12/10/18
12/10
14:05
12/10/18
14:05
Options
AGNC Investment Corp. call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROAD

Construction Partners

$8.90

-0.25 (-2.73%)

14:03
12/10/18
12/10
14:03
12/10/18
14:03
Recommendations
Construction Partners analyst commentary  »

Construction Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

QTM

Quantum

$2.17

-0.02 (-0.91%)

14:02
12/10/18
12/10
14:02
12/10/18
14:02
Hot Stocks
Breaking Hot Stocks news story on Quantum »

TCW Group reports 12.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DSW

DSW

$23.31

-0.92 (-3.80%)

14:00
12/10/18
12/10
14:00
12/10/18
14:00
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Dec

CASY

Casey's General Stores

$119.68

-1.74 (-1.43%)

, SFIX

Stitch Fix

$26.93

0.59 (2.24%)

14:00
12/10/18
12/10
14:00
12/10/18
14:00
Earnings
Notable companies reporting after market close »

Notable companies…

CASY

Casey's General Stores

$119.68

-1.74 (-1.43%)

SFIX

Stitch Fix

$26.93

0.59 (2.24%)

ASNA

Ascena Retail

$3.02

0.01 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 10

    Dec

  • 11

    Dec

TVPT

Travelport

$15.68

0.28 (1.82%)

13:56
12/10/18
12/10
13:56
12/10/18
13:56
Downgrade
Travelport rating change  »

Travelport downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$360.79

2.95 (0.82%)

, GM

General Motors

$34.03

-0.67 (-1.93%)

13:50
12/10/18
12/10
13:50
12/10/18
13:50
OnTheFly
Tesla CEO discusses 'lack of respect for SEC,' use of Twitter in 60 Minutes interview »

In an interview on…

TSLA

Tesla

$360.79

2.95 (0.82%)

GM

General Motors

$34.03

-0.67 (-1.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

EQT

EQT Corporation

$19.41

0.99 (5.37%)

13:50
12/10/18
12/10
13:50
12/10/18
13:50
Options
Bullish option spread in EQT as shares see relative strength »

Bullish option spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

RARX

RA Pharmaceuticals

$18.85

2.4 (14.59%)

, ALXN

Alexion

$113.77

-1.9 (-1.64%)

13:46
12/10/18
12/10
13:46
12/10/18
13:46
Recommendations
RA Pharmaceuticals, Alexion analyst commentary  »

RA Pharmaceuticals could…

RARX

RA Pharmaceuticals

$18.85

2.4 (14.59%)

ALXN

Alexion

$113.77

-1.9 (-1.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

  • 12

    Dec

  • 18

    Feb

CIDM

Cinedigm

$0.76

-0.0302 (-3.82%)

13:42
12/10/18
12/10
13:42
12/10/18
13:42
Hot Stocks
Cinedigm announces content licensing deal with Starrise Media »

Cinedigm announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAPL

Apple

$168.25

-0.12 (-0.07%)

, QCOM

Qualcomm

$57.05

1.05 (1.88%)

13:40
12/10/18
12/10
13:40
12/10/18
13:40
Periodicals
Apple says filed appeal against iPhone sales ban in China, CNBC reports »

Apple (AAPL) told CNBC…

AAPL

Apple

$168.25

-0.12 (-0.07%)

QCOM

Qualcomm

$57.05

1.05 (1.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HYGS

Hydrogenics

$4.51

-0.005 (-0.11%)

13:40
12/10/18
12/10
13:40
12/10/18
13:40
Options
Call buyer in Hydrogenics as shares fall to 52-week lows »

Call buyer in Hydrogenics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
12/10/18
12/10
13:40
12/10/18
13:40
General news
Fed Policy Outlook: analysts expect the FOMC to hike rates 25 bps next week »

Fed Policy Outlook:…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.